Compare Revvity Inc (RVTY) vs WEC Energy Group Inc. Common Stock (WEC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Revvity Inc vs WEC Energy Group Inc. Common Stock — how do they compare? Revvity Inc trades at $155 (market cap $16.97B), while WEC Energy Group Inc. Common Stock trades at $107.87 (market cap $34.78B). The key difference: WEC Energy Group Inc. Common Stock is far larger — about 2× Revvity Inc's market cap, and WEC Energy Group Inc. Common Stock pays the higher dividend (3.57%). Which is the better fit depends on your goals — on Pluang, investors hold Revvity Inc for 13 Days and WEC Energy Group Inc. Common Stock for 0 Days on average.
| RVTY | WEC | |
|---|---|---|
Market Cap | $16.97B | $34.78B |
Volume | 1,602,713 | 2,317,952 |
Sector | Health | Utilities |
52-Week High | $157.36 | $118.85 |
52-Week Low | $82.26 | $100.78 |
Typical Hold Time | 13 Days | 0 Days |
Enterprise Value | $19.29B | $57.74B |
Dividend Yield | 0.18% | 3.57% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RVTY trades at $155.08, down 0.34% today but near its 52-week high of $158.28. The stock shows a bullish technical trend with strong moving average support. Recent earnings beats and a Zacks upgrade to Buy reflect positive momentum. The company launched a new Type 1 diabetes screening kit in Europe and announced the acquisition of Human Cell Design, expanding its metabolic disease research tools.
Outlook remains positive with revenue stability and margin pressures manageable. Investment opportunity lies in diagnostic growth and AI-driven demand, though premium valuation and China market risks warrant caution. The absence of sell ratings and strong institutional accumulation support a constructive view, but rich multiples require sustained earnings delivery for further upside.
WEC Energy Group trades at $105.87, up 0.92% with neutral technical signals. The stock shows strong fundamentals with consistent earnings beats (Q2 2026 EPS of $0.91 vs. $0.804 expected) and improving profitability (net margin 16.7%). Recent news highlights growing data center demand as a key growth driver, with the company engaging in large-scale customer discussions for 400-500 megawatt projects.
WEC presents a compelling utility investment with stable cash flows and dividend potential, though faces interest rate sensitivity. Analyst consensus targets $118.33 (12% upside) with majority Hold ratings. Key risks include regulatory pressures and capital expenditure requirements for infrastructure expansion through 2030.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →About WEC Energy Group Inc. Common Stock
WEC Energy Group is a Midwest electric and natural gas utility holding company whose subsidiaries, including We Energies and Wisconsin Public Service, deliver electricity and natural gas to customers in Wisconsin, Illinois, Michigan, and Minnesota.
Read more on WEC →
